8-K

ACCENDRA HEALTH INC/VA/ (ACH)

8-K 2024-05-24 For: 2024-05-24
View Original
Added on April 10, 2026

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 24, 2024

Owens & Minor, Inc .

(Exact name of registrant as specified in its charter)

Virginia 001-09810 54-1701843
(State or other jurisdiction of (Commission (I.R.S. Employer
incorporation or organization) File Number) Identification No.)
9120 Lockwood Boulevard ,<br><br>Mechanicsville , Virginia 23116
(Address of principal executive
offices) (Zip Code)
Post Office Box 27626,
Richmond, Virginia 23261-7626
(Mailing address of principal
executive offices) (Zip Code)

Registrant’s telephone number, including area code (804) **** 723-7000

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, $2 par value per share OMI New York Stock Exchange

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.below):

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company         ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ​ ​

Item 5.02Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On May 24, 2024, Owens & Minor, Inc. (the Company) named Jennifer Stone (53) Executive Vice President & Chief Human Resources Officer of the Company effective June 3, 2024. Before joining the Company, Ms. Stone was Vice President of Human Resources, Medical Surgical Portfolio, Surgical Operating Unit at Medtronic, a global medical device company. She also spent more than 20 years at Target Corporation, a retail company, in various roles of increasing responsibility, including most recently as Head of Talent Management.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

OWENS & MINOR, INC.
Date: May 24, 2024 By: /s/ Heath H. Galloway
Name: Heath H. Galloway
Title: Executive Vice President, General Counsel and Corporate Secretary